Filing search / Wave Life Sciences Ltd. / "Pandemic" / Page 2

8-K

EX-99.1

ar67r1 g22i5q

4 Apr 22

Reductions in poly(GP), a key disease biomarker indicating target engagement, observed across all treatment groups after single doses

7:35am

8-K

EX-99.1

pu71u

3 Mar 22

Wave Life Sciences Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update

7:37am

8-K

EX-99.1

udj4o8 mo423bgk275d

10 Nov 21

Wave Life Sciences Reports Third Quarter 2021 Financial Results and Provides Business Update

7:36am

8-K

EX-99.1

7vr5 3eo0

5 Aug 21

Wave Life Sciences Reports Second Quarter 2021 Financial Results and Provides Business Update

7:38am

8-K

EX-99.1

50xx o5jefhn

13 May 21

Wave Life Sciences Reports First Quarter 2021 Financial Results and Provides Business Update

7:37am

8-K

EX-99.1

2qjwdtxa g22uk3

29 Mar 21

Wave Life Sciences Provides Update on Phase 1b/2a PRECISION-HD Trials

4:09pm

8-K

EX-99.1

f5o64

4 Mar 21

Wave Life Sciences Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

7:06am

8-K

EX-99.2

dnsj1l zh49xici

11 Jan 21

Regulation FD Disclosure

8:07am

8-K

EX-99.1

1e25yvb4gmbx

9 Nov 20

Wave Life Sciences Reports Third Quarter 2020 Financial Results and Provides Business Update

7:37am

424B5

vng5xaae umxxq9m5

23 Sep 20

Prospectus supplement for primary offering

4:17pm

8-K

EX-99.2

3lkemkp

22 Sep 20

Wave Life Sciences Announces Proposed Public Offering of Ordinary Shares

4:17pm